Tisch MS News

Tuesday, April 29th Today’s Tisch MS Center poster presentations included: Transient Neurologic Worsening after Initiation of Dimethyl Fumarate Therapy in Progressive Multiple Sclerosis Patients James W Stark, Sydney Chirls, Saud Sadiq Summary: We identified 18 patients with progressive forms of MS...

May 1, 2014

More

By Dr. James W. Stark A study presented at the AAN examined the use of estriol in combination with copaxone in the treatment of 158 relapsing-remitting MS patients. At 12 months, the group treated with both copaxone and estriol had improved relapse rates, however that effect was less apparent at 24...

May 1, 2014

More

We are pleased to announce the stem cell research from Tisch MSRCNY has been selected to be presented as a highlight during the Annual Meeting of the American Academy of Neurology. This will take place later today during the portion of the Meeting pertaining to MS. We will provide an update for you...

April 30, 2014

More

Please read our press release on the success of the Tisch MSRCNY Phase I Clinical Stem Cell Trial campaign on Indiegogo.com. To continue to support this important initiative CLICK HERE . We are truly grateful to everyone who is helping to fund our mission to repair the damage caused by multiple...

April 15, 2014

More

Tisch MS Research Center of New York is delighted to announce that it has received regulatory approval needed to commence our proposed phase I clinical trial of mesenchymal stem cell-derived neural progenitor cells for the treatment of progressive multiple sclerosis. Patient enrollment and the...

March 17, 2014

More

Tisch MS Research Center of New York continues to be in active deliberation with an Institutional Review Board regarding approval of our stem cell clinical trial. We expect to have all outstanding concerns addressed in the near future and will begin study activities at that time. Please note that...

February 27, 2014

More

Tisch MS Research Center of New York submitted our FDA-approved protocol for review by an Institutional Review Board (IRB), an organization designated by the Department of Health and Human Services (HHS) to monitor and supervise research involving human subjects, whose approval is a regulatory...

January 31, 2014

More

The Tisch MS Research Center has had twelve scientific research presentations accepted to the 66 th annual meeting of the American Academy of Neurology. The conference is the largest gathering of the neurological community in the world and will take place at the end of April in Philadelphia. Twelve...

January 28, 2014

More

The Tisch MSRCNY Phase I Clinical Stem Cell Trial was featured on the CBS Evening News on Monday, January 20th. For those of you who missed the segment, CBS has posted the video and a text article on the study and its approval. Please share the link with all of your family and friends. http://www...

January 21, 2014

More

The Multiple Sclerosis Discovery Forum features a new article on the work of Dr. Massimiliano Cristofanilli and his team at the Tisch MS Research Center of New York in developing the first animal model of progressive MS: But what did surprise the team, Cristofanilli said, were the lesions they...

December 17, 2013

More

Pages

Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Look for the IFF Building on the North side of 57th Street across from the CBS building

Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.